Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tunefumi Shibuya"'
Autor:
Hiroshi Matsuoka, Eijo Matsuishi, Shoichiro Ikeda, Naokuni Uike, Y. Izumi, H Gondoh, Masato Masuda, Seiichi Okamura, Junichi Tsukada, Tunefumi Shibuya, Fumio Kawano, Shuichi Hanada, Atae Utsunomiya, Kazuo Tamura, Yutaka Imamura, Yoshio Saburi
Publikováno v:
American Journal of Hematology. 71:248-255
1998, a consensus meeting was held in Miyazaki, Japan, to develop an approach to management of febrile neutropenia (FN). The K-HOT study group decided to examine whether this proposal was applicable to clinical practice in a multicenter study. Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26863d138869d7262db82d96bb6298c5
https://doi.org/10.1002/ajh.10236
https://doi.org/10.1002/ajh.10236
Autor:
Kazuo Tamura, Junji Suzumiya, Takao Shibata, Masamichi Tomonaga, Masahiro Kikuchi, Junichi Tukada, Tunefumi Shibuya
Publikováno v:
Internal Medicine. 41:283-289
Objective To clarify the efficacy of chemotherapy after radiation therapy in immunocompetent patients with primary central nervous system lymphoma (PCNSL). Patients and Methods A retrospective analysis of 22 PCNSL patients was performed. Twenty-two p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a34d4c48f249689539e6d6612a25be
https://doi.org/10.2169/internalmedicine.41.283
https://doi.org/10.2169/internalmedicine.41.283
Autor:
Naokuni Uike, Fumio Kawano, Tunefumi Shibuya, Seiichi Okamura, Hisashi Gondo, Kazuo Tamura, Junichi Tsukada, Y. Izumi, Junji Suzumiya, Atae Utsunomiya, Shoichiro Ikeda, Tetsuya Fukuda, Sawada H
Publikováno v:
European Journal of Haematology. 67:152-157
Chronic lymphocytic leukemia (CLL) is a rare disease in Japan. Recent advances in molecular biology, diagnostic criteria and classification of CLL have reinforced the concept of each category of CLL as a distinct entity. Since there have been no rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cd1d6d8f1b1945d64d14e204aec9090
https://doi.org/10.1034/j.1600-0609.2001.5790514.x
https://doi.org/10.1034/j.1600-0609.2001.5790514.x
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 94(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d015fb3f9ae848a9f9ac7cd58577cfe1
https://pubmed.ncbi.nlm.nih.gov/15768599
https://pubmed.ncbi.nlm.nih.gov/15768599
Autor:
Junji Suzumiya, Hitoshi Suzushima, Kouichi Maeda, Seiichi Okamura, Atae Utsunomiya, Tunefumi Shibuya, Kazuo Tamura, Kyushu Hematology Organization for Group
Publikováno v:
International journal of hematology. 79(3)
A phase I study of irinotecan hydrochloride (CPT-11), carboplatin, and dexamethasone treatment in 7 patients with relapsed lymphoma and 7 patients with refractory lymphoma was conducted to evaluate the maximal tolerated dose. The 6 female and 8 male
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7adb1fc9d248dce920f653a498011260
https://pubmed.ncbi.nlm.nih.gov/15168596
https://pubmed.ncbi.nlm.nih.gov/15168596